Global Home Global Home  
 
 

 

 

Press Releases

= Add Release to Briefcase

DATE

TITLE

 
Nov 16, 2017 Sonoma Pharmaceuticals Announces FDA Approval of Expanded Indication for Alevicyn™ to Add Antimicrobial Language PDF 17.9 KB Add to Briefcase
 
 
Nov 9, 2017 Sonoma Pharmaceuticals Reports Robust Top Line Growth for Second Quarter FY 2018 with 61% Product Revenue Growth and Total Revenue of $4.3 Million PDF 48.0 KB Add to Briefcase
 
 
Oct 31, 2017 Sonoma Pharmaceuticals Receives Brazilian Approvals to Market Multiple Hypochlorous Acid-Based Dermatology Products PDF 20.4 KB Add to Briefcase
 
 
Oct 26, 2017 Sonoma Pharmaceuticals Announces Fiscal Second Quarter 2018 Financial Results and Conference Call PDF 16.6 KB Add to Briefcase
 
 
Oct 3, 2017 Sonoma Pharmaceuticals Announces U.S. Commercialization of Loyon® for Relief of Scaling, Burning and Itching Associated with Various Dermatoses Including Seborrhea and Seborrheic Dermatitis PDF 20.1 KB Add to Briefcase
 
 
Sep 14, 2017 Sonoma Pharmaceuticals Announces Commercialization of MicrocynAH® Animal Healthcare Products in Japan PDF 20.7 KB Add to Briefcase
 
 
Aug 8, 2017 Sonoma Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018 PDF 41.9 KB Add to Briefcase
 
 
Jul 25, 2017 Sonoma Pharmaceuticals Announces Fiscal First Quarter 2018 Financial Results and Conference Call PDF 16.9 KB Add to Briefcase
 
 
Jul 13, 2017 CORRECTING and REPLACING -- Sonoma Pharmaceuticals Announces Record Quarterly Prescription Data PDF 21.5 KB Add to Briefcase
 
 
Jul 13, 2017 Sonoma Pharmaceuticals Announces Record Quarterly Prescription Data PDF 21.1 KB Add to Briefcase
 

Showing 1-10 of 69

Page: 1 2 3 ... 7

 Next 10